pemetrexed

You have access
A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based Chemotherapy
JWA HOON KIM, CHANGHOON YOO, HYEHYUN JEONG, JAEKYUNG CHEON, KYU-PYO KIM, BAEK-YEOL RYOO, HEUNG-MOON CHANG, CHUNG RYUL OH, HYE WON RYU and INKEUN PARK

Anticancer Research September 2025, 45 (9) 3983-3991; DOI: https://doi.org/10.21873/anticanres.17756
You have access
Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective Study
SUNG HEE LIM, JUNG YONG HONG, JOON OH PARK, YOUNG SUK PARK and SEUNG TAE KIM

Anticancer Research September 2023, 43 (9) 4161-4167; DOI: https://doi.org/10.21873/anticanres.16607
You have access
Can Previous Chemotherapy Affect the Outcome of Nivolumab Treatment in Non-small Cell Lung Cancer?
MARTIN SVATON, MONIKA BRATOVA, LEONA KOUBKOVA, ONDREJ FISCHER, BOHUSLAV MELICHAR, MICHAL HRNCIARIK, DANIEL DOLEZAL, ONDREJ BILEK, JANA KREJCI, MARIE DROSSLEROVA, ZDENKA DLOUHA, JIRI BLAZEK, PETRA MAJKOVA, LUCIE BROZOVA and MAREK STASTNY

Anticancer Research April 2022, 42 (4) 1987-1995; DOI: https://doi.org/10.21873/anticanres.15677
You have access
A Novel Molecular Target in EGFR-mutant Lung Cancer Treated With the Combination of Osimertinib and Pemetrexed
NATSUKI TAKANO, MASAHIRO SEIKE, TEPPEI SUGANO, KUNIKO MATSUDA, KAKERU HISAKANE, AKIKO YOSHIKAWA, SHINJI NAKAMICHI, RINTARO NORO and AKIHIKO GEMMA

Anticancer Research February 2022, 42 (2) 709-722; DOI: https://doi.org/10.21873/anticanres.15529
You have access
Pemetrexed Disodium Heptahydrate Induces Apoptosis and Cell-cycle Arrest in Non-small-cell Lung Cancer Carrying an EGFR Exon 19 Deletion
MD MOHIUDDIN and KAZUO KASAHARA

Anticancer Research June 2021, 41 (6) 2963-2977; DOI: https://doi.org/10.21873/anticanres.15078
You have access
Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment
DANIEL KREJCI, PETR OPALKA, JANA KREJCI, MILADA ZEMANOVA, PETRA ZEMANOVA, JURAJ KULTAN, ONDREJ FISCHER, JANA SKRICKOVA, MONIKA BRATOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, HELENA COUPKOVA, KAROLINA HURDALKOVA, MAGDA BARINOVA, LEONA KOUBKOVA, DANIEL DOLEZAL, MARTIN SAFANDA, MILOS PESEK and MARTIN SVATON

Anticancer Research May 2021, 41 (5) 2597-2603; DOI: https://doi.org/10.21873/anticanres.15039
You have access
A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
HIRONORI YOSHIDA, YOUNG HAK KIM, YUICHI SAKAMORI, HIROKI NAGAI, HIROAKI OZASA, TOSHIHIKO KANEDA, HIROSHIGE YOSHIOKA, HIROAKI NAKAGAWA, KEISUKE TOMII, ASUKA OKADA, KENICHI YOSHIMURA, MASATAKA HIRABAYASHI and TOYOHIRO HIRAI

Anticancer Research May 2020, 40 (5) 2981-2987; DOI: https://doi.org/10.21873/anticanres.14278
You have access
Hedgehog Pathway Activation Might Mediate Pemetrexed Resistance in NSCLC Cells
YICHAO LIU, RUDOLF M. HUBER, ROSEMARIE KIEFL, AMANDA TUFMAN and DIEGO KAUFFMANN-GUERRERO

Anticancer Research March 2020, 40 (3) 1451-1458; DOI: https://doi.org/10.21873/anticanres.14087
You have access
An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer
KYOICHI KAIRA, HISAO IMAI, RYOUSUKE SOUMA, REIKO SAKURAI, YOSUKE MIURA, NORIAKI SUNAGA, NORIMITSU KASAHARA, YUSUKE TSUKAGOSHI, YASUHIKO KOGA, SHINSUKE KITAHARA, MIE KOTAKE, KOICHI MINATO, ICHIRO NARUSE, YASUTSUGU FUKUSHIMA, TAKESHI HISADA and TAMOTSU ISHIZUKA

Anticancer Research May 2019, 39 (5) 2483-2491; DOI: https://doi.org/10.21873/anticanres.13368
You have access
TTF-1 Expression Predicts the Merit of Additional Antiangiogenic Treatment in Non-squamous Non-small Cell Lung Cancer
AKIRA TAKEUCHI, TETSUYA OGURI, YORIKO YAMASHITA, KAZUKI SONE, SATOSHI FUKUDA, OSAMU TAKAKUWA, TAKEHIRO UEMURA, KEN MAENO, KENSUKE FUKUMITSU, YOSHIHIRO KANEMITSU, HIROTSUGU OHKUBO, MASAYA TAKEMURA, YUTAKA ITO and AKIO NIIMI

Anticancer Research September 2018, 38 (9) 5489-5495; DOI: https://doi.org/10.21873/anticanres.12882

Main menu

User menu

Search

pemetrexed

Pages